In support of this notion, nasal injection of insulin was effective to improve cognitive functions in a pilot study in AD.78 Furthermore, GLP-1 analog exenatide was effective in a pilot study in PD.84 Thus, given that immunotherapy alone is not efficient for behaviors, sensitization of insulin receptor signaling may be important. The gene discussed is GLP1R; the disease is Alzheimer disease.